- Correction
- Open access
- Published:
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
BMC Infectious Diseases volume 21, Article number: 185 (2021)
The Original Article was published on 23 January 2021
Correction to: BMC Infect Dis 21, 112 (2021)
https://doi.org/10.1186/s12879-021-05802-8
After publication of the original article [1], the authors identified an error in the first affiliation.
The incorrect affiliation is:
Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan, Wangfujing Street, Beijing 100730, China
The correct affiliation is:
Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
The original article has been corrected.
Reference
Xu, et al. BMC Infect Dis. 2021;21:112. https://doi.org/10.1186/s12879-021-05802-8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Xu, L., Peng, W., Song, X. et al. Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study. BMC Infect Dis 21, 185 (2021). https://doi.org/10.1186/s12879-021-05880-8
Published:
DOI: https://doi.org/10.1186/s12879-021-05880-8